STK Delays Public Sale To Coincide with Public Beta Testing

STK is delaying its Token Generation Event to coincide with STACK’s public beta launch in January, 2018. The public token sale will run from January 31 to February 14, 2018.

Gibraltar - December 7, 2017 /MarketersMedia/ —

December 7, 2017, Gibraltar – STK is delaying its Token Generation Event to coincide with STACK’s public beta launch in January, 2018. The public token sale will run from January 31 to February 14, 2018. The STK pre-sale is currently running and will end as scheduled on December 10, 2017 at 16:59 UTC.

STK is the first mass market instant cryptocurrency payment solution, providing access to more than 33 million merchants around the world.

“There is a growing demand for improved liquidity of cryptocurrency,” said Miro Pavletic, Director of STK. “Having a beta product in the market during our token sale will provide the first public proof-of-concept in the cryptocurrency payments space and solidify our position as the premiere mass market solution for instant crypto payments at point of sale.”

STK is also reducing its hard cap to $17MM USD, projecting early traction to support funding for future deliverables.

“Based on the response from our community and investment network, we’re anticipating fast growth in our initial markets,” said Pavletic. “This will allow us to replace a higher hard cap with early revenue, fuelling international expansion and supporting a larger user base.”

The STK token supply will remain the same at 500,000,000, of which 55% will be available for sale for a total public supply of 275,000,000. The token price has been updated to $0.10 USD. Token distribution will be based on the conversion rates from Ether to USD 24 hours before the close of the public sale or when the sale hard cap is reached, whichever comes first.

For full sale information, visit www.stktoken.com.

About STK Global Payments
STK Global Payments is the cryptocurrency technology solution which enables real-time cryptocurrency payments at points of sale, and the issuer of the STK token. The STK token was designed to provide a method that can allow cryptocurrency to be used instantly at retail for seamless integration into everyday transactions and financial services. The STK token will be implemented on the public Ethereum blockchain as an ERC20 token. The STK token is part of a global solution to facilitate borderless transactions through a smart contract which facilitates a real-time exchange of cryptocurrency into fiat at the POS.
For more information on the STK token, visit www.stktoken.com.

Contact Info:
Name: Amanda Ashford
Email: amanda@getstack.ca
Organization: STK Global Payments

Source URL: https://marketersmedia.com/stk-delays-public-sale-to-coincide-with-public-beta-testing/274926

For more information, please visit https://stktoken.com

Source: MarketersMedia

Release ID: 274926

Latest News

AP Exclusive: Stephen Hawking's wheelchair, thesis for sale

Oct 23, 2018

LONDON — Stephen Hawking was a cosmic visionary, a figure of inspiration and a global celebrity. His unique status is reflected in an upcoming auction of some of the late physicist's possessions: It includes complex scientific papers, one of the world's most iconic wheelchairs and a script from "The Simpsons." The online sale announced Monday by auctioneer Christie's features 22 items from Hawking, including his doctoral thesis on the origins of the universe, some of his many awards, and scientific papers such as "Spectrum of Wormholes" and "Fundamental Breakdown of Physics in Gravitational Collapse." Thomas Venning, head of books and...

Japanese Nobel chemistry laureate Shimomura dies at 90

Oct 23, 2018

TOKYO — Japanese-born Marine biologist Osamu Shimomura, who won the Nobel Prize in chemistry, has died. He was 90. His alma mater Nagasaki University said Monday that Shimomura died Friday of natural causes. Shimomura and two American scientists shared the 2008 Nobel prize for the discovery and development of a jellyfish protein that later contributed to cancer studies. Shimomura was born in northern Kyoto in 1928 and studied in Nagasaki, where he survived the Aug. 9, 1945, U.S. atomic bombing at age 16. His high school education was cut short during World War II as he was mobilized to work...

Melting glacier in China draws tourists, climate worries

Oct 23, 2018

YULONGXUESHAN, China — The loud crack rang out from the fog above the Baishui No. 1 Glacier as a stone shard careened down the ice, flying past Chen Yanjun as he operated a GPS device. More projectiles were tumbling down the hulk of ice that scientists say is one of the world's fastest melting glaciers. "We should go," said the 30-year-old geologist. "The first rule is safety." Chen hiked away and onto a barren landscape once buried beneath the glacier. Now there is exposed rock littered with oxygen tanks discarded by tourists visiting the 15,000-foot (4,570-meter) -high blanket of ice...

Ex-spy chief says Brexit leaves UK vulnerable to attack

Oct 23, 2018

LONDON — Brexit could leave Britain more vulnerable to attacks like the nerve-agent poisoning of a Russian ex-spy in Salisbury, a former head of the U.K.'s overseas intelligence service said Friday. "I don't believe Russia would have used a nerve agent on the streets of an American or German city" because the consequences would be too great, John Sawers, who led MI6 between 2009 and 2014, said.. Sawers was speaking at an event in Salisbury, southwest England, where ex-spy Sergei Skripal and his adult daughter, Yulia, were poisoned in March with the military-grade nerve agent Novichok. Britain alleges the attack...

EU drug agency urges approval for dengue vaccine

Oct 23, 2018

LONDON — Europe's drug regulator has recommended approving the first vaccine for dengue despite concerns about the vaccine's wide use and a lawsuit in the Philippines alleging that it was linked to three deaths. The European Medicines Agency said Friday it had adopted a "positive opinion" of French pharmaceutical company Sanofi's Dengvaxia. The vaccine is the world's first against dengue, which sickens about 96 million people annually. The mosquito-spread virus is found in tropical and sub-tropical climates across Latin and South America, Asia, Africa and elsewhere. It produces a flu-like disease that can cause joint pain, nausea, vomiting and a...

About Us

Frontal Report is an emerging leader in all forms of media. We aim to be the leading news brand for readers around the world.

Contact us: sales[at]frontalreport.com

Subscribe Now!